Eledon Pharmaceuticals

$10.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.55 (-4.86%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ELDN and other stocks, options, and ETFs commission-free!

About ELDN

Eledon Pharmaceuticals, Inc. Common Stock, also called Eledon Pharmaceuticals, is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people requiring an organ or cellular transplant, and for people living with autoimmune and neurodegenerative disease.

CEO
David-Alexandre C. Gros
Employees
10
Headquarters
Irvine, California
Founded
2004
Market Cap
152.86M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
28.03K
High Today
$11.19
Low Today
$10.56
Open Price
$11.19
Volume
28.34K
52 Week High
$27.32
52 Week Low
$6.16

ELDN Earnings

-$3.90
-$2.60
-$1.30
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 11, After Hours

You May Also Like

IDEV
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure